메뉴 건너뛰기




Volumn 39, Issue 10, 2000, Pages 1330-1333

Genetics of childhood disorders: XIX. ADHD, Part 3: Is ADHD a noradrenergic disorder?

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYL 5 (1 METHYL 2 PYRROLIDINYL)ISOXAZOLE; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMFEBUTAMONE; AMITRIPTYLINE; ATOMOXETINE; BUSPIRONE; CLONIDINE; DESIPRAMINE; GUANFACINE; IMIPRAMINE; METHYLPHENIDATE; MONOAMINE OXIDASE INHIBITOR; NORADRENALIN; NORTRIPTYLINE; PROTRIPTYLINE; TERTIARY AMINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

EID: 0033818549     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-200010000-00024     Document Type: Short Survey
Times cited : (27)

References (8)
  • 4
    • 85031605460 scopus 로고    scopus 로고
    • NIMH. Alternative Pharmacology of ADHD (NIMH report). Rockville, MD: National Institute of Mental Health
    • (1996)
  • 5
    • 0032127304 scopus 로고    scopus 로고
    • Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: A review and integration
    • (1998) Behav Brain Res , vol.94 , pp. 127-152
    • Solanto, M.1
  • 8
    • 0001799787 scopus 로고
    • Noradrenergic hypothesis of attention deficit disorder with hyperactivity: A critical review
    • Psychopharmacology: The Third Generation of Progress, Meltzer HY, ed. New York: Raven
    • (1987) , pp. 837-842
    • Zametkin, A.J.1    Rapoport, J.L.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.